SCHEMBL382262

SCHEMBL382262

CNC(=O)c1n[nH]c2c1ccc1cncnc12

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
YTHDC1 Q96MU7 1/20 0.45
PAK1 Q13153 4/20 0.38
CCNC P24863 3/20 0.37
CDK8 P49336 3/20 0.37
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
JAK3 P52333 1/20 0.36
DYRK1A Q13627 3/20 0.36
MAPK1 P28482 1/20 0.35
FLT3 P36888 1/20 0.35
CSNK2A1 P68400 1/20 0.33
WNT1 P04628 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 2/20 0.32
EGFR P00533 1/20 0.32
PDE10A Q9Y233 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1558505 0.84 CSNK2A2 (0.35) CSNK2A1
Hydrochloric Acid SCHEMBL6052926 0.83 CSNK2A2 (0.34) CSNK2A1
SCHEMBL29377248 0.83 RPS6KB1 (0.36) JAK2JAK1TYK2JAK3CSNK2A1
SCHEMBL1559078 0.83 RPS6KB1 (0.36) JAK2JAK1TYK2JAK3CSNK2A1
Hydrochloric Acid SCHEMBL1560043 0.82 RPS6KB1 (0.35) JAK2JAK1TYK2JAK3CSNK2A1
Phosphoric Acid SCHEMBL20600153 0.81 RPS6KB1 (0.33) JAK2JAK1TYK2JAK3
SCHEMBL382261 0.78 EIF2AK4 (0.39) YTHDC1PAK1CCNCCDK8CSNK2A1
Trifluoroacetic Acid SCHEMBL9936778 0.77 L3MBTL1 (0.34) CSNK2A1
SCHEMBL6634413 0.68 YTHDC1 (0.47) YTHDC1PAK1CCNCCDK8JAK2
SCHEMBL666445 0.68 PLK1 (0.50) FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125822-A1 SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2009-12-02 EP claimed
EP-1986632-A1 COMBINATIONS COMPRISING A CDK INHIBITOR AND A GROWTH FACTOR ANTIBODY OR ANTI-MITOTIC NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2008-11-05 EP claimed
WO-2008074788-A1 SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2008-06-26 WO claimed
WO-2007090794-A1 COMBINATIONS COMPRISING A CDK INHIBITOR AND A GROWTH FACTOR ANTIBODY OR ANTI-MITOTIC NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2007-08-16 WO claimed
EP-2408776-A1 USE OF A KINASE INHIBITOR FOR THE TREATMENT OF THYMOMA Nerviano Medical Sciences S.r.l. (IT) 2012-01-25 EP disclosed
EP-2323664-A1 USE OF A CDK INHIBITOR FOR THE TREATMENT OF GLIOMA Nerviano Medical Sciences S.r.l. (IT) 2011-05-25 EP disclosed
EP-2320903-A1 THERAPEUTIC COMBINATION COMPRISING A CDKs INHIBITOR AND AN ANTINEOPLASTIC AGENT Nerviano Medical Sciences S.r.l. (IT) 2011-05-18 EP disclosed
WO-2010012733-A9 USE OF A CDK INHIBITOR FOR THE TREATMENT OF GLIOMA NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-04-14 WO disclosed
WO-2010106028-A1 USE OF A KINASE INHIBITOR FOR THE TREATMENT OF THYMOMA NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-09-23 WO disclosed
WO-2010012777-A1 THERAPEUTIC COMBINATION COMPRISING A CDKs INHIBITOR AND AN ANTINEOPLASTIC AGENT NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-02-04 WO disclosed
WO-2010012733-A1 USE OF A CDK INHIBITOR FOR THE TREATMENT OF GLIOMA NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-02-04 WO disclosed
EP-1636236-A1 PYRAZOLO-QUINAZOLINE DERIVATIVES,PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2006-03-22 EP disclosed
WO-2004104007-A1 PYRAZOLO-QUINAZOLINE DERIVATIVES,PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS PHARMACIA ITALIA S.P.A. (IT) 2004-12-02 WO disclosed